Patient information
The Welsh Medicines Advice Service produces information on different medicines for patients.
Patient Information and Leaflets (including Welsh translations)
Patient information leaflet for switching to an aflibercept biosimilar (English) also available in Welsh
Patient information about antibiotics:
Giving children antibiotics when liquid preparations are not available (English), also available in Welsh
Patient information leaflet for switching from another DOAC to apixaban (English) also available in Welsh.
Patient information leaflet for switching from another DOAC to rivaroxaban (English) also available in Welsh.
Patient information about COVID-19 treatments:
Patient information leaflet for switching to a denosumab biosimilar (English) also available in Welsh
Patient information about stock shortages of GLP-1 analogues
GLP-1 analogues stock shortages (English) also available in Welsh
Advice for patients on how herbal treatments or ‘herbal medicines’ and homeopathic remedies can affect anti-cancer therapy (English) also available in Welsh
This information has been developed for use within Cardiff and Vale University Health Board.
The leaflet and card have been developed by CAVUHB primary care prescribing advisors without input from WMAS.
While externally developed, we believe this content has undergone appropriate governance and review processes. WMAS publish this content to support safe and effective patient care.
Medication sick day rules leaflet (English) also available in Welsh
Medicines sick day rules card (English) also available in Welsh
Patient information leaflet about treatment for Mpox virus:
Tecovirimat (English) also available in Welsh
Patient information leaflet for switching to an ustekinumab biosimilar (English) also available in Welsh
The Welsh Government recently confirmed that certain weight management medications – tirzepatide, semaglutide and liraglutide (known as glucagon-like peptide-1, or GLP-1, receptor agonists) – should only be prescribed in the NHS in Wales through specialist weight management services.
For more details, please refer to the Welsh Health Circular (WHC/2025/018), available on the gov.wales website.
Patient Information Videos
Inhalers – prescribing, use, disposal
AWTTC in collaboration with the Welsh Government, Public Health Wales, Asthma and Lung UK, and Cardiff Metropolitan University have developed these videos to improve the prescribing, use and disposal of inhalers in Wales.
Welsh Translations of National Patient Information
The resources below are Welsh translations of nationally used patient information.
Yellow Card Scheme – information in Welsh
Adult and paediatric steroid cards and leaflets in Welsh
Local Health Board Patient Information
Patient information leaflets produced by Local Health Boards(password access required)
26 Mar 26
Denosumab PIL added.
31 Dec 25
Aflibercept PIL added.
06 Dec 25
ADHD medicines shortage PIL and metolazone PIL removed.
18 Sep 25
CAVUHB Medication sick day rules leaflet and card updated.
16 Jun 25
CAVUHB Medication sick day rules leaflet and card added.
28 Jan 25
Ustekinumab PIL updated.
08 Nov 24
Herbal and homeopathic medicines and anti-cancer therapies PIL added. Rivaroxaban PIL added.
09 Oct 24
ADHD medicines shortage PIL added.
25 Sep 24
Ustekinumab PIL added.
25 Jun 24
Patient videos links on inhaler prescribing, use and disposal added.
10 Jun 24
Updated metolazone PILs added (English and Welsh).
23 Apr 24
Updated solid dosage forms of antibiotics for children when liquids are unavailable PIL added.
19 Mar 24
Added ABUHB Emollient PILs
28 Jan 24
Removed biosimilar and generic equivalent information as no longer relevant
18 Jan 24
Link to new Cerdyn Melyn leaflet updated
15 Nov 23
Apixaban PIL added.
31 Jul 23
GLP-1 stock shortages leaflet added.
07 Jan 23
Reformat and removal of out of date information. Addition of Metalozone PIL.
09 Dec 22
Solid dosage forms of antibiotics for children when liquids are unavailable PIL added.
15 Sep 22
Link to YCS leaflet updated.
08 Aug 22
Link to Tramadol AWMSG leaflets added.
